NCT06985147View on ClinicalTrials.gov

A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 12, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2029

Conditions
Polycythemia Vera (PV)
Interventions
DRUG

DISC-3405

DISC-3405 is administered subcutaneously.

Trial Locations (5)

32224

RECRUITING

Mayo Clinic in Florida, Jacksonville

55905

RECRUITING

Mayo Clinic in Minnesota, Rochester

77030

RECRUITING

MD Anderson Cancer Center, Houston

85054

RECRUITING

Mayo Clinic in Arizona, Phoenix

90095

RECRUITING

UCLA Health, Los Angeles

Sponsors

Lead Sponsor

Disc Medicine, Inc
All Listed Sponsors
lead

Disc Medicine, Inc

INDUSTRY

NCT06985147 - A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV) | Biotech Hunter | Biotech Hunter